Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studies.

Pediatric blood & cancer·2017

Same author

Right foot congenital infantile fibrosarcoma treated only with chemotherapy.

Pediatric blood & cancer·2010

Same author

Polytetrafluoroethylene patch repair of a saccular abdominal aortic aneurysm in a 5-year-old boy.

Journal of pediatric surgery·2005

Same author

Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2005

Same author

Intestinal alpha beta T cells differentiate and rearrange antigen receptor genes in situ in the human infant.

Journal of immunology (Baltimore, Md. : 1950)·2004

Same author

Intestinal obstruction due to malrotation.

Journal of the Royal Society of Medicine·2004

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Neonatal sarcoma.

Richard D Spicer¹

¹University of Bristol, UK. rdspicer@hotmail.com

Early Human Development

|October 5, 2010

Summary

This summary is machine-generated.

Neonatal soft tissue tumors often behave more favorably than those in older children, requiring less aggressive treatment. Accurate diagnosis and modified chemotherapy are key, while radiotherapy should be avoided.

More Related Videos

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Related Experiment Videos

Last Updated: Jun 8, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Area of Science:

Pediatric Oncology
Surgical Pathology
Neonatal Medicine

Background:

Neonatal soft tissue tumors present unique biological and clinical characteristics.
Many neonatal tumors exhibit distinct, more favorable behavior compared to adult or older pediatric counterparts.
This distinct behavior influences treatment strategies and prognoses.

Purpose of the Study:

To highlight the distinct nature of neonatal soft tissue tumors.
To emphasize the need for tailored treatment approaches in neonates.
To guide optimal management strategies, including diagnosis and therapy selection.

Main Methods:

Review of clinical data and pathological findings for neonatal soft tissue tumors.
Comparison of tumor behavior and treatment outcomes between neonatal and older pediatric populations.
Analysis of treatment modalities, including surgery, chemotherapy, and radiotherapy.

Main Results:

Neonatal soft tissue tumors often demonstrate a more favorable natural history.
Surgical resection alone is curative for a significant proportion of these tumors.
Modified chemotherapy dosages and regimens are crucial for minimizing adverse effects in neonates.

Conclusions:

Accurate histological diagnosis is paramount for appropriate management.
Less aggressive treatment strategies are often warranted for neonatal soft tissue tumors.
Radiotherapy should be avoided due to significant risks of long-term adverse effects, including impaired growth and secondary malignancies.